Crawley-based pioneers’ mission: to offer hope to all cancer patients

At Elekta, we have a united purpose that motivates us as a company and as individuals – hope for everyone dealing with cancer. It drives us towards our vision – a world where everyone has access to the best cancer care, and we plan to get there through our mission –to improve patient lives by working together with our customers and partners.

Elekta is working to drive adoption across the globe with our ACCESS 2025 strategy, which aims to make radiotherapy accessible to 300 million more people in underserved markets by 2025.

For over half a century, we’ve been collaborating proactively with clinicians and our partners to develop solutions that meet evolving patient needs, no matter where they are in the world. Our global team of 4,000 employees combine passion, science and innovation to profoundly change cancer care, improve patient care and bring hope to everyone dealing with cancer.

Last year, it was 50 years since Elekta was founded. While our expansion did not begin in earnest until the early 1980s, our focus has remained unchanged: to make a meaningful impact on health care providers and their patients globally by delivering the best and safest clinical solutions. Listening to our customers and really understanding their needs has enabled us to push the boundaries of cancer care.

We have pioneered technologies within our extensive product portfolio from neurosurgery with the Leksell Gamma Knife, brachytherapy for specific internal tumours to advanced radiotherapy techniques with our suite of linear accelerators, and the advancement of adaptive radiotherapy using the pioneering MR linac, Elekta Unity.

In January 2022, we inaugurated the Elekta Foundation; its mission to initiate and support projects and programmes in partnership with governments and healthcare providers to improve access to cancer care in underserved regions and communities. The foundation focuses on three areas: n expand education to close knowledge gaps in radiotherapy n increase awareness and prevention in cervical cancer n strengthen cancer care infrastructure through new tools and models.

OUR CRAWLEY BUILT ‘MANOR ROYAL’ LINAC SOLUTIONS

Linear accelerators, or ‘linacs’, are the cornerstone of radiotherapy departments, treating a wide range of cancers and allowing patients to receive their care as an outpatient. Elekta’s linac solutions have been built in Manor Royal for 50 years and are designed to help clinicians raise the quality of care by tailoring treatments to each patient while still improving productivity so that more patients can receive treatment. November 2022 saw the 6,000 Linac machine built in Crawley – a magnificent achievement.

We look forward to the next 50 years of Elekta in Manor Royal.